Recap: Designing Better Medicines Through Big Data and AI
BenevolentAI is “a new revolution in drug discovery and development,” according to Joanna Shields, CEO. She shared how their AI platforms are key components in both discovery and development. Their goal is to create treatments to those challenging diseases that have no cure. “Our mission at Benevolent is to unlock the potential of scientific data, […]